Relevant bibliographies by topics / Antisense nucleic acids

Academic literature on the topic 'Antisense nucleic acids'

Author: Grafiati
Published: 4 June 2021
Last updated: 31 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antisense nucleic acids.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antisense nucleic acids"

1

Goodchild, John. "Antisense nucleic acids and proteins." Cell Biophysics 18, no. 3 (June 1991): 295–96. http://dx.doi.org/10.1007/bf02989820.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Razzak, Mina. "Antisense nucleic acids—tough delivery." Nature Reviews Urology 10, no. 12 (November 19, 2013): 681. http://dx.doi.org/10.1038/nrurol.2013.271.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Soomets, Ursel. "Antisense properties of peptide nucleic acids." Frontiers in Bioscience 4, no. 1-3 (1999): d782. http://dx.doi.org/10.2741/soomets.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Langel, Ülo. "Antisense properties of peptide nucleic acids." Frontiers in Bioscience 4, no. 4 (1999): d782–786. http://dx.doi.org/10.2741/a394.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tonkinson, J. L., and C. A. Stein. "Antisense Nucleic Acids — Prospects for Antiviral Intervention." Antiviral Chemistry and Chemotherapy 4, no. 4 (August 1993): 193–200. http://dx.doi.org/10.1177/095632029300400401.

Full text
Abstract:
Antisense oligodeoxynucleotides are a promising new class of antiviral agent. Because they bind in a sequence-specific manner to complementary regions of mRNA, oligos can inhibit gene expression in a sequence-specific manner. The ‘antisense’ approach has been used successfully to block cellular expression and replication of several viruses including Human Immunodeficiency Virus-1 (HIV-1), and Herpes Simplex Virus (HSV). However, the antiviral effect of oligodeoxynucleotides is not limited to sequence-specific inhibition of gene expression. Non sequence-specific effects are frequently observed, presumably as a result of their properties as polyanions. Occasionally (e.g. for HIV-1) these non sequence-specific effects are also therapeutic. The prospects for antisense oligodeoxynucleotide therapy for viral disease are discussed.
APA, Harvard, Vancouver, ISO, and other styles
6

Morihiro, Kunihiko, Yuuya Kasahara, and Satoshi Obika. "Biological applications of xeno nucleic acids." Molecular BioSystems 13, no. 2 (2017): 235–45. http://dx.doi.org/10.1039/c6mb00538a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Malcolm, Alan D. B. "Uses of antisense nucleic acids — an introduction." Biochemical Society Transactions 20, no. 4 (November 1, 1992): 745–46. http://dx.doi.org/10.1042/bst0200745.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Flores, Maria Vega C., David Atkins, Thomas Stanley Stewart, Arthur van Aerschot, and Piet Herdewijn. "Antimalarial antisense activity of hexitol nucleic acids." Parasitology Research 85, no. 10 (August 24, 1999): 864–66. http://dx.doi.org/10.1007/s004360050647.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Nielsen, Peter. "Targeting structured nucleic acids with antisense agents ▾." Drug Discovery Today 8, no. 10 (May 2003): 440. http://dx.doi.org/10.1016/s1359-6446(03)02702-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Li, Hui, Bohan Zhang, Xueguang Lu, Xuyu Tan, Fei Jia, Yue Xiao, Zehong Cheng, et al. "Molecular spherical nucleic acids." Proceedings of the National Academy of Sciences 115, no. 17 (April 9, 2018): 4340–44. http://dx.doi.org/10.1073/pnas.1801836115.

Full text
Abstract:
Herein, we report a class of molecular spherical nucleic acid (SNA) nanostructures. These nano-sized single molecules are synthesized from T8 polyoctahedral silsesquioxane and buckminsterfullerene C60 scaffolds, modified with 8 and 12 pendant DNA strands, respectively. These conjugates have different DNA surface densities and thus exhibit different levels of nuclease resistance, cellular uptake, and gene regulation capabilities; the properties displayed by the C60 SNA conjugate are closer to those of conventional and prototypical gold nanoparticle SNAs. Importantly, the C60 SNA can serve as a single entity (no transfection agent required) antisense agent to efficiently regulate gene expression. The realization of molecularly pure forms of SNAs will open the door for studying the interactions of such structures with ligands and living cells with a much greater degree of control than the conventional polydisperse forms of SNAs.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Antisense nucleic acids"

1

Abbas, Sahar. "Design and synthesis of backbone-modified nucleic acids." Thesis, University of Nottingham, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.368273.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bijapur, Jeevan. "Factors affecting the stability of nucleic acids." Thesis, University of Southampton, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.299497.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Slaitas, Andis. "Development of a new PNA analogue as a potential antisense drug and tool for life-science studies /." Stockholm : Karolinska institutet, 2004. http://diss.kib.ki.se/2004/91-7349-642-1/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Dryselius, Rikard. "Bacterial gene expression inhibition with antisense peptide nucleic acids /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-338-8/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dysko, Anna Monika. "Synthesis and properties of oligonucleotides containing triazole backbone linkages and 2'-modifications for therapeutic applications." Thesis, University of Oxford, 2016. https://ora.ox.ac.uk/objects/uuid:20fc1203-9751-4654-b497-5f4d97f874a1.

Full text
Abstract:
Antisense oligonucleotides are short strands of DNA, which bind to their complementary mRNA target to prevent protein translation. Although conceptually appealing, for their practical use as drugs, these oligonucleotides must have better cellular uptake, resistance to enzymatic degradation, and target selectivity. In this work, new synthetic chemistry is established to prepare a novel group of chemically modified oligonucleotides. The anionic phosphodiester backbone is partially replaced with a neutral triazole and, at the same time, the 2'-position of the ribose sugar is functionalised with pyrene, anthraquinone, or guanidine moieties. Being unnatural, the triazole backbone is inherently resistant to enzymatic degradation, while the reduced negative charge potentially improves cell penetration. The limitation of introduction of a triazole backbone into the antisense strand is its destabilising effect on the duplex formation with their complementary target. In this study, the 2'-modifications are used to restore the lost duplex stability and they have been found to be very efficient stabilising moieties. To evaluate the viability of this strategy, reporter gene assays based on splice-switching model are used. Promisingly, these modified oligonucleotides have successfully shown antisense splice-switching activity, suggesting there is further scope for their improvement.
APA, Harvard, Vancouver, ISO, and other styles
6

Lewis, Karen Jane. "Biodegradable polymers for the sustained release of antisense nucleic acids." Thesis, Aston University, 1996. http://publications.aston.ac.uk/11054/.

Full text
Abstract:
Antisense oligodeoxynucleotides can selectively inhibit individual gene expression provided they remain stable at the target site for a sufficient period of time. Thus, the efficacy of antisense oligodeoxynucleotides may be improved by employing a sustained release delivery system which would protect from degradation by nucleases whilst delivering the nucleic acid in a controlled manner to the site of action. Biodegradable polymer films and micro spheres were evaluated as delivery devices for the oligodeoxynucleotides and ribozymes. Polymers such as polylactide, polyglycolide, polyhydroxybutyrate and polyhydroxyvalerate were used due to their biocompatability and non toxic degradation products. Release profiles of antisense nucleic acids from films over 28 days was biphasic, characterised by an initial burst release during the first 48 hours followed by a more sustained release. Release from films of longer antisense nucleic acids was slower compared to shorter nucleic acids. Backbone type also affected release, although to a lesser extent than length. Total release of the nucleic acids is dependent upon polymer degradation, no degradation of the polymer films was evident over the 28 day period, due to the high molecular weight and crystallinity of the polymers required to make solvent cast films. Backbone length and type did not affect release from microspheres, release was generally faster than from films, due to the increased surface area, and low molecular weight polymers which showed signs of degradation over the release period, resulting in a triphasic release profile. An increase in release was observed when sphere size and polymer molecular weight were decreased. The polymer entrapped phosphodiester oligodeoxynucleotides and ribozymes had enhanced stability compared to free oligodeoxynucleotides and ribozymes when incubated in serum. The released nucleic acids were still capable of hybridising to their target sequence, indicating that the fabrication processes did not adversely effect the properties of the antisense nucleic acids. Oligodeoxynucleotides loaded in 2μm spheres had a 10 fold increase in macrophage association compared to free oligodeoxynucleotides. Fluorescent microscopy indicates that the polymer entrapped oligodeoxynucleotide is concentrated inside the cell, whereas free oligodeoxynucleotides are concentrated at the cell membrane. Biodegradable polymers can reduce the limitations of antisense therapy and thus offer a potential therapeutic advantage.
APA, Harvard, Vancouver, ISO, and other styles
7

Dong, Shuzhi Dong Shuzhi. "I. Restriction of DNA conformation by spirocyclic annulation at C-4' II. Studies toward the enantioselective synthesis of pestalotiopsin A /." Columbus, Ohio : Ohio State University, 2007. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=osu1174627553.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Xu, Jian, and 徐堅. "Using antisense oligonucleotide in whole embryo culture to study gene interactions during mouse gastrulation." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1998. http://hub.hku.hk/bib/B31220150.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Xu, Jian. "Using antisense oligonucleotide in whole embryo culture to study gene interactions during mouse gastrulation /." Hong Kong : University of Hong Kong, 1998. http://sunzi.lib.hku.hk/hkuto/record.jsp?B19918884.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

McCracken, Meredith A. "Role of protein kinase C isoforms in human breast tumor cell survival." Morgantown, W. Va. : [West Virginia University Libraries], 2002. http://etd.wvu.edu/templates/showETD.cfm?recnum=2441.

Full text
Abstract:
Thesis (Ph. D.)--West Virginia University, 2002.
Title from document title page. Document formatted into pages; contains xii, 161 p. : ill. (some col.). Vita. Includes abstract. Includes bibliographical references (p. 140-158).
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Antisense nucleic acids"

1

A, Stein Cy, and Krieg Arthur M, eds. Applied antisense oligonucleotide technology. New York: Wiley-Liss, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mol, Joseph N. M., 1948- and Krol, Alexander R. van der, 1956-, eds. Antisense nucleic acids and proteins: Fundamentals and applications. New York: M. Dekker, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

H, Murray James A., ed. Antisense RNA and DNA. New York: Wiley-Liss, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ugent, Steven Jay. Antisense oligonucleotides: Psoralen photoreactivity and enzymatic resistance. [S.l: s.n.], 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

G, Hernandes A., ed. Antisense elements (genetics) research focus. Hauppauge, N.Y: Nova Science Publishers, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lewis, Karen Jane. Biodegradable polymers for the sustained release of antisense nucleic acids. Birmingham: Aston University. Department of Biological and Pharmaceutical Sciences, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Saghir, Akhtar, ed. Delivery strategies for antisense oligonucleotide therapeutics. Boca Raton: CRC Press, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

C, Taylor Jessica, and Williams Amelia J, eds. Research progress in antisense elements (genetics). New York: Nova Science, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Derek, Chadwick, Cardew Gail, and Symposium on Oligonucleotides as Therapeutic Agents (1997 : Ciba Foundation), eds. Oligonucleotides as therapeutic agents. Chichester: Wiley, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

1922-, Weiss Benjamin, ed. Antisense oligodeoxynucleotides and antisense RNA: Novel pharmacological and therapeutic agents. Roca Raton, Fla: CRC Press, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Antisense nucleic acids"

1

Houba-Hérin, N., and M. Inouye. "Antisense RNA." In Nucleic Acids and Molecular Biology, 210–20. Berlin, Heidelberg: Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-46596-3_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Goh, Shan, Jem Stach, and Liam Good. "Antisense Effects of PNAs in Bacteria." In Peptide Nucleic Acids, 223–36. Totowa, NJ: Humana Press, 2013. http://dx.doi.org/10.1007/978-1-62703-553-8_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Goltermann, Lise, and Peter E. Nielsen. "PNA Antisense Targeting in Bacteria: Determination of Antibacterial Activity (MIC) of PNA-Peptide Conjugates." In Peptide Nucleic Acids, 231–39. New York, NY: Springer US, 2020. http://dx.doi.org/10.1007/978-1-0716-0243-0_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Liang, Xue-hai, Timothy A. Vickers, and Stanley T. Crooke. "Antisense-Mediated Reduction of Eukaryotic Noncoding RNAs." In From Nucleic Acids Sequences to Molecular Medicine, 191–214. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-27426-8_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gait, Michael J., and Sudhir Agrawal. "Introduction and History of the Chemistry of Nucleic Acids Therapeutics." In Methods in Molecular Biology, 3–31. New York, NY: Springer US, 2022. http://dx.doi.org/10.1007/978-1-0716-2010-6_1.

Full text
Abstract:
AbstractThis introduction charts the history of the development of the major chemical modifications that have influenced the development of nucleic acids therapeutics focusing in particular on antisense oligonucleotide analogues carrying modifications in the backbone and sugar. Brief mention is made of siRNA development and other applications that have by and large utilized the same modifications. We also point out the pitfalls of the use of nucleic acids as drugs, such as their unwanted interactions with pattern recognition receptors, which can be mitigated by chemical modification or used as immunotherapeutic agents.
APA, Harvard, Vancouver, ISO, and other styles
6

Eritja, Ramon, Montserrat Terrazas, Santiago Grijalvo, Anna Aviñó, Adele Alagia, Sónia Pérez-Rentero, and Juan Carlos Morales. "Challenges and Opportunities for Oligonucleotide-Based Therapeutics by Antisense and RNA Interference Mechanisms." In Chemical Biology of Nucleic Acids, 227–42. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-54452-1_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Magistri, Marco, and Mohammad Ali Faghihi. "Natural Antisense Transcripts Mediate Regulation of Gene Expression." In From Nucleic Acids Sequences to Molecular Medicine, 247–74. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-27426-8_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Caruso, Gerardo, Mariella Caffo, Giuseppe Raudino, Federica Raudino, Mario Venza, and Francesco Tomasello. "Antisense Oligonucleotides in the Treatment of Malignant Gliomas." In From Nucleic Acids Sequences to Molecular Medicine, 215–46. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-27426-8_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Di Cresce, Christine, Colin Way, Mateusz Rytelewski, Saman Maleki Vareki, Supritha Nilam, Mark D. Vincent, James Koropatnick, and Peter J. Ferguson. "Antisense Technology: From Unique Laboratory Tool to Novel Anticancer Treatments." In From Nucleic Acids Sequences to Molecular Medicine, 145–89. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-27426-8_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Stetsenko, Dmitry A. "Mesyl Phosphoramidate Oligonucleotides: A New Promising Type of Antisense Agents." In Handbook of Chemical Biology of Nucleic Acids, 1–41. Singapore: Springer Nature Singapore, 2023. http://dx.doi.org/10.1007/978-981-16-1313-5_19-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Antisense nucleic acids"

1

Van Aerschot, Arthur, Mark Vandermeeren, Johan Geysen, Walter Luyten, Marc Miller, David Atkins, Sonia Preveral, Ester Saison-Behmoaras, and Piet Herdewijn. "In vitro evaluation of hexitol nucleic acid antisense oligonucleotides." In XIth Symposium on Chemistry of Nucleic Acid Components. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 1999. http://dx.doi.org/10.1135/css199902151.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Marzenell, Paul D., Helen Hagen, Larisa Kovbasyuk, and Andriy Mokhir. "Chemically modified phosphorothioate DNA and 2'-OMe RNA as antisense agents." In XVth Symposium on Chemistry of Nucleic Acid Components. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2011. http://dx.doi.org/10.1135/css201112391.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Wojtczak, Blazej A., Agnieszka Andrysiak, and Zbigniew J. Lesnikowski. "An approach towards synthesis of antisense oligonucleotides modified with lipophilic boron clusters via "click chemistry" method." In XIVth Symposium on Chemistry of Nucleic Acid Components. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2008. http://dx.doi.org/10.1135/css200810482.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ravn, Jacob, Maj Hedtjärn, Niels Fisker, Joachim Elmén, Marie W. Lindblom, Henrik F. Hansen, Michael Meldgaard, Ellen M. Straarup, Jens B. Hansen, and Christoph Rosenbohm. "Locked nucleic acid antisense oligonucleotides targeting apolipoprotein B: the effect of short sequences and α-L-LNA insertion." In XVth Symposium on Chemistry of Nucleic Acid Components. Prague: Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2011. http://dx.doi.org/10.1135/css201112444.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Greco, Francesca, Elena Cesaro, Andrea Falanga, Rosa Catapano, Simona Romano, Nicola Borbone, Arianna Pastore, et al. "A novel antisense strategy peptide nucleic acid-based to downregulate CD5 expression in chronic lymphocytic leukemia." In 7th International Electronic Conference on Medicinal Chemistry. Basel, Switzerland: MDPI, 2021. http://dx.doi.org/10.3390/ecmc2021-11396.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Levin, Arthur A., Lee M. Greenberger, Aby Buchbinder, Bo R. Hansen, Maj Hedtjärn, Sakari Kauppinen, Henrik Oerum, and Ivan D. Horak. "Abstract SY31-02: Locked nucleic acid (LNA)-modified antisense oligonucleotides as anticancer agents: Using high-affinity antisense molecules in the laboratory and in the clinic." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-sy31-02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Brown, Paige K., Ammar T. Qureshi, Daniel J. Hayes, and W. Todd Monroe. "Targeted Gene Silencing With Light and a Silver Nanoparticle Antisense Delivery System." In ASME 2011 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2011. http://dx.doi.org/10.1115/sbc2011-53647.

Full text
Abstract:
Targeted delivery and controlled release of oligonucleotide therapeutics in vivo are essential aspects of an ideal delivery vehicle. Here we demonstrate the synthesis and in vitro/intracellular characterization of silver nanoparticle (SNP) photolabile nucleic acid conjugates, with the aim of developing a nanoparticulate platform for inducible gene silencing. Due to unique size related properties, nanostructures are being increasingly utilized for intracellular diagnostics and delivery applications. While most nanoscale delivery platforms are polymeric in composition, studies of metallic nanoparticles have highlighted their suitability for delivery of therapeutic agents such as antisense oligonucleotides [1]. The potential benefits of noble metal nanoparticles in delivery applications include tunable size and shape, ease of bulk synthesis and functionalization via ‘wet chemistry’ techniques, and enhanced stability of tethered DNA [2]. Silver is one of the best surface-enhancing substrates available for nanostructure synthesis [3]. SNP composites afford external control over surface-tethered drug release via external triggers.
APA, Harvard, Vancouver, ISO, and other styles
8

Thomas, Sufi M., Shrinivas Rapiredd, Bichismita Sahu, Sonali Joyce, and Danith Ly. "Abstract C175: Antisense EGFR guanidium‐based peptide nucleic acid (GPNA) oligomers as an antitumor agent for head and neck cancer." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-c175.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Klar, Richard, Clara Seger, Nicole Kirchhammer, André Maaske, Julia Festag, Laura Fernandez Rodriguez, Mélanie Buchi, et al. "434 Targeting the expression of Neuropilin-1 by locked nucleic acid modified antisense oligonucleotides results in potent anti-tumor activity in vivo." In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0434.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sapra, Puja, Yixian Zhang, Stephen Castaneda, Steven Kim, Patricia Kraft, Raj Bandaru, Lee M. Greenberger, and Ivan D. Horak. "Abstract C144: A locked nucleic acid antisense oligonucleotode against androgen receptor, down‐modulates target mRNA and causes antitumor effects in xenograft models of prostate cancer." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Nov 15-19, 2009; Boston, MA. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/1535-7163.targ-09-c144.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Antisense nucleic acids' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography